Everything is the body in interconnected. Isn’t it amazing how if one thing is out of whack, the rest of the body suffers? Have you ever stubbed your toe so badly that it was then hard to walk? One little toe can wreak havoc on the state of the rest of your body.
Here at McKenna Orthopedics, we believe in getting you up and running so you can live your best life. Whether its your toe or your back, we want to help.’
We offer a pleathora of options and procedures, so you can be confident in your treatment plan. Dr. Wade McKenna has performed over 20,000 surgeries, and with his expertise and innovation, we are hopeful that you will experience healing.
You may be experiencing knee pain or shoulder pain. Maybe your back pain has become unmanageable. Whatever stage in life you are in, we want to be in your mind as the best place to come to receive the treatment you deserve.
At McKenna Orthopedics, we offer solutions both surgical, and non-surgical that will get you back into the game, faster and with great results.
We would love to connect with you, and start the conversation so you can get back to doing life, and living out your best days.
Q. Why should I choose McKenna Orthopedics over another clinic?
A. At McKenna Orthopedics, we take pride in serving our patients with care, compassion and unique procedures to get you back in the game of life quickly, and with less discomfort. Dr. Wade McKenna has performed over 20,000 surgeries and procedures, so you can be confident that you are in good hands.
Q. What is the biggest advantage of undergoing a Stemnexa-Rx™ treatment?
A. The biggest advantage of non-surgical Stemnexa procedure is, under the right circumstances, avoiding surgery. Many of our patients get back to the activities they love within a matter of months, and they avoid going under the knife.
Q. How can stem cell therapy help me and my current condition?
A. Many patients that have aches, whether it be the elbow or the knee, can benefit from a procedure using Stemnexa. Cell therapy helps to revascularize, which is a big word for allowing oxygen to reach the tissues, which can then reduce inflammation, prevent cell death. It can actually help the damaged tissue repair itself.
Q. Will I need surgery or can I just use stem cell therapy to help me feel better?
A. At McKenna Orthopedics, we will review your history, review any MRIs, and talk with you in person. We strive to perform the least invasive and effective procedure that we can, because that means that you feel better sooner rather than later.
Q. If I do need surgery, do you use stem cells too?
A. It depends, but we certainly try to incorporate Stemnexa-Sx™ when we can. Using a biologic like Stemnexa can allow the patient a faster recovery as well as reduction in complications and infection.
Want to learn more? Feel free to reach out to us. We would love to continue the conversation with any more questions you have. We look forward to connecting.
The backbone is important. Sayings have derived over the years that include the notion of “the backbone” of the society, or “the backbone” the family. Why would this be? It’s probably because the backbone, also known as the spine is so important for the body to function.
Suffering doesn’t have to be a lifetime sentence. If you are dealing with chronic back pain from herniated or bulging disc, pinched nerve, or lumbar injury, we can step in and take the reigns. Here at McKenna Orthopedics, we have the expertise to get you healthy again. We know you are the backbone to someone, and we have the solutions to get you back to your best.
Traditional surgery may be the solution for you, depending on the severity of your injury or pain. Our board-certified surgeons have treated thousands of patients with excellent results. If going under the knife feels extreme, another option is using stem cell technology to help heal quickly, without the downtime of traditional surgery.
How can stem cells help my lower back pain?
A 2015 study published in the scientific journal, Stem Cells, reported that patients suffering from chronic back pain due to degenerative disc disease who were treated by injections of their own bone marrow aspirate concentrate (BMAC) into the lumbar discs experienced noteworthy pain reduction one year after treatment.
Improvement in pain scores and impairment was demonstrated in 21 of 26 patients, with the most dramatic improvement in patients with higher CFU-F concentrations. Rehydration of the discs in eight of twenty patients according to MRI in conjunction with sustained pain relief through one year is promising for the use of this regenerative medicine approach.
At McKenna Orthopedics, we utilize tried and true techniques, but also incorporate new technologies, such as stem cell therapy, to bring our care to the next level. We strive to create healthy and beneficial results for our patients, because we know how important your mobilization is.
Did you ever know just how important your knees are? The knees act like a hinge, and provide steadiness and strength to support the entire body. That’s right, the entire body. Your knees serve as a critical function for standing, walking and running of course, and the fun-filled motions like dancing, jumping, twirling and turning.
When a knee (or knees) give out, it can affect your entire body, even your entire wellbeing. It may affect your ability to perform sports, or even basic functions like standing up from your favorite chair or walking outside to get the mail.
Knee replacement surgery is of course an option, and a really good option to get up and running (or walking) again. Dallas-based board certified orthopedic surgeon, Dr. Wade McKenna has performed over 20,000 surgeries, so he is more than qualified to make any repairs to your precious knees. But what if there was a quicker way to heal without a complete knee overhaul?
One of the breakthrough technologies that Dr. McKenna specializes in is called Stemnexa. Stemnexa combines a patient’s own bone marrow stem cells with amniotic tissue (donated from a mother after a live birth) to treat bone, muscle, tendon, ligament and cartilage injury in the knee. The amniotic tissue that Dr. McKenna uses in the procedure is composed of collagens and other proteins, which provide solution that supports both tissue growth and new collagen production during tissue regeneration and repair process. Though it sounds technical, the bottom line is that this procedure works, and patients have had amazing results from this relatively not invasive method.
Not sure what the next option is? We are here to help. If you are suffering with pain or discomfort, we would love to help ease your aches. If you are interested in either traditional surgery or learning more on how Stemnexa can benefit you, contact us today at firstname.lastname@example.org. We are so excited to connect, and get to know you, and your knees better.
The cost of surgery goes beyond just the dollars and cents that come out of your pocketbook. Recovery time is a large price to pay when you go under the knife. But what if there was an easier and faster way to heal?
Enter stem cell therapy, Stemnexa. At McKenna Orthopedics, Dr. R. Wade McKenna leads the way to healing non-invasively. Pretty cool, huh?
So how exactly does it work?
Stem cell therapy may look a bit different for each application, but here is the gist.
We take human amniotic tissue (donated afterbirth from a mama who has delivered a live healthy baby) and utilize its components to inject the therapy where the patient is having problematic issues.
This cell therapy pumps oxygen to the tissue, reduces pesky inflammation all the while, preventing cell death. We want all the alive and well cells we can get, am I right?
The actual procedure takes less than your hour-long lunch break, and patients can potentially be on their feet in under a week.
Using the Stemnexa technology is the best way to heal quickly, and get back on your feet sooner than if you were to undergo traditional, under the knife surgery.
If you are interested or want to learn more about this super space-aged technology, fill out this easy questionnaire to see if you’re a candidate, and someone from our office will get back to you in a timely fashion. We are ready to make the connection, and we care about your health so you can live out your best life.
Still have questions? Feel free to send us a note, and we will be more than happy to get you in the right direction. You can also reach us at 940-627-6976. We understand how important it is to get back into your regular routines, so reach out today.
Background and purpose – The value of core decrompression for treatment of osteonecrosis of the femoral head (ONFH) is unclear. We investigated by a literature review whether implantation of autologous bone marrow aspirate, containing high concentrations of pluripotent mesenchymal stem cells, into the core decompression track would improve the clinical and radiological results compared with the classical method of core decompression alone. The primary outcomes of interest were structural failure (collapse) of the femoral head and conversion to total hip replacement (THR). Patients and methods – All randomized and non-randomized control trials comparing simple core decompression with autologous bone marrow cell implantation into the femoral head for the treatment of ONFH were considered eligible for inclusion. The methodological quality of the studies included was assessed independently by 2 reviewers using the Cochrane Collaboration tool for assessing risk of bias in randomized studies. Of 496 relevant citations identified, 7 studies formed the basis of this review. Results – The pooled estimate of effect size for structural failure of the femoral head favored the cell therapy group, as, in this treatment group, the odds of progression of the femoral head to the collapse stage were reduced by a factor of 5 compared to the CD group (odds ratio (OR) = 0.2, 95% CI: 0.08-0.6; p = 0.02). The respective summarized estimate of effect size yielded halved odds for conversion to THR in the cell therapy group compared to CD group (OR = 0.6, 95% CI: 0.3-1.02; p = 0.06). Interpretation – Our findings suggest that implantation of autologous mesenchymal stem cells (MSCs) into the core decompression track, particularly when employed at early (pre-collapse) stages of ONFH, would improve the survivorship of femoral heads and reduce the need for hip arthroplasty.
UCLA wide receiver and Canadian decathlon standout Zach Bornstein suffered a hamstring tear 18 months ago. Conventional treatment and therapy were not working so Zach decided to undergo stem cell therapy at Riordan-McKenna Institute in late June 2015. Dr. McKenna treated Zack with precisely guided injections of bone marrow aspirate concentrate (BMAC) harvested with the patented BioMAC bone marrow aspiration cannula and *AlphGEMS amniotic tissue product.
Complete healing was confirmed by MRI 8 weeks after treatment:
1) No evidence for hamstring strain or denervation and no evidence for tendon tear.
2) No evidence for focal atrophy or hematoma.
3) No osseous abnormalities seen.
After receiving the MRI results, Zack’s father Dean said, “I am not a doctor but looks like you and your procedure has performed a medical miracle! …Thanks for all of your efforts.”
Zack is currently a red shirt freshman at UCLA. He played football at Oaks Christian High School from 2011-’14 and lettered 3 years in football and all 4 years in track. In 2013, Zack was named to the All-Marmonte 2nd team. He played in the FBU Youth All-American game in 2010. In track, he is considered to be one of the top decathletes in the country. Zack competed at the 2013 Pan American Junior Championships in Medellin, Columbia, finishing in 5th place with 7,097 points. In July of 2013, he became the Canadian Junior National Champion (6,918 pts). Zack won the silver medal at the 2013 Arcadia Invitational Decathlon, scoring 6,967 points to set a new California state record for juniors (2nd highest score in California state history). Zack is a 12-time National Champion, 44-time All-American and a member of three National Championship cross country teams.
*Amniotic tissue is donated after normal, healthy births.
Over the last five years, R. Wade McKenna, DO, founder of North Central Texas Orthopedics and Sports Medicine of Decatur, Texas and McKenna Orthopedics of Trophy Club, Texas, has treated over 3,000 patients with point-of-care Autologous Biologic Therapy (ABT). ABT is the use of a patient’s own regenerative cells and other growth factors to promote and accelerate the body’s natural healing cascade. With the recent news of high profile athletes such as Alex Rodriguez, Kobe Bryant, Tiger Woods and Peyton Manning traveling overseas for similar treatment, we asked Dr. McKenna if this technology is unavailable or unapproved in the United States.
Dr. McKenna replies with a chuckle, “Neither of those assumptions is true. In fact, I began using point-of-care Autologous Biologic Therapy to aid in the healing of rotator cuff surgeries more than five years ago. My initial use of ABT was directed toward improving surgical results only in rotator cuff surgery. However, the positive effect the addition of this biologic therapy had on rotator cuff surgical outcomes was so impressive I began to expand the use of this novel treatment to other difficult-to-treat injuries and conditions. The only reason I can think of as to why these athletes went overseas is because they’ve never heard of my practice in Decatur, Texas.”
The use of a patient’s own growth factors derived from platelet-rich plasma (PRP) has been a popular treatment for sports related ligament and tendon injuries. McKenna adds, “Initially the focus centered on the wound care market where PRP showed promising results. We began to understand the healing powers found in whole blood, and early adaptors such as myself incorporated the therapy into our patient care protocols. For Kobe Bryant and Alex Rodriguez, their treatments contained stem cells not found in whole blood. Most of the physicians in the U.S. don’t have experience in point-of-care Autologous Biologic Therapy so high-profile athletes such as these seek treatment with cultured stem cells in Europe.”
Both Bryant and Rodriguez were seeking a clinical culturing process of their own stem cells to achieve a desired number of these regenerative cells that would produce a positive outcome. In the U.S., the FDA has yet to approve stem cell culturing for the purpose of treating these injuries, causing most Americans to seeking this treatment to travel overseas.
In Decatur, Texas, Dr. McKenna uses a centrifuge to achieve similar large numbers of regenerative cells and administers them to his patients in an FDA approved point-of-care procedure. The processing is done while the patient is undergoing treatment for his/her injury and takes less than 25 minutes. In Europe the cells are cultured in a laboratory and administered to the patient two to three days later, which is a procedure that is not FDA approved.
The method Dr. McKenna uses to acquire a patient’s regenerative cells from his/her bone marrow does not require culturing. “I began utilizing regenerative cells in point-of-care treatments for orthopedic related complications over five years ago. Back then I was limited to surgical applications due to the archaic method of bone marrow harvest and the lack of a sophisticated processing device. The new Bio-MAC bone marrow aspiration cannula from Biologic Therapies changes all that,” says McKenna.
Previous to recent advances in technology by Biologic Therapies, Inc. (BTI), obtaining bone marrow aspirate was a difficult and painful process using a hammer-driven cannula (needle). “I was fortunate to have a business contact that was focused on bringing marrow harvesting and processing out of the dark ages. Together, we collaborated on designing a state-of-the-art harvesting device, the Bio-MAC Bone Marrow Aspiration Cannula, as well as developing a centrifuge system capable of concentrating millions of regenerative cells from the blood products in the harvested marrow. I’m very proud of our development and feel BTI’s Bio-MAC will revolutionize the emerging point-of-care Autologous Biologic Therapy market,” said McKenna.
Dr. McKenna has joined forces with Biologic Therapies of Ocala, Florida. “Biologic Therapies is our medical think tank,” explains McKenna. “We are now able to further the advancement of Autologous Biologic Therapy while promoting the business of point-of-care regenerative medicine. No other company I’m aware of combines the two.” Point-of-care refers to the process of harvesting regenerative cells from bone marrow and reintroducing those cells back into the patient is one, quick procedure without any culturing of the cells.
With the use of technology he developed with Biologic Therapies, Dr. McKenna has successfully drawn regenerative cells from the bone marrow of his patients in an in-office setting. These new advancements have made obtaining bone marrow aspirate and the use of regenerative cells a much easier and cost efficient point-of-care process.
One of the most innovative uses of bone marrow aspirate concentrate, which was pioneered by Dr. McKenna, involves treating arthritic knees. “Arthritis is technically just the absence of articular cartilage covering the joint surfaces. Many times small arthritic lesions develop which are called osteochondral defects. These defects often progress to severe changes involving the entire joint,” explains McKenna.
Currently, the standard of care for these osteochondral defects or arthritic lesions is a surgery called microfracture. In microfracture surgery an arthroscopic procedure is performed to create small fractures through the underlining cancellous bone to treat the defect. These small holes help promote healing by the liberation of small amounts of bone marrow within the joint.
“My initial thought involving this process was that if small drops of liberated bone marrow aided in healing of these lesions, what would the addition of active regenerative cells from concentrated bone marrow aspirate be capable of doing?” states McKenna. This thinking led to the development of a protocol to treat patients with not only isolated osteochondral lesions, but also to treat patients with more severe osteoarthritis.
Dr. McKenna adds, “The growth of articular cartilage is common in children as they develop into adults and cartilage volume increases. Unfortunately, the growth of articular cartilage in adults is rare and treatment for the loss of cartilage has been focused on replacing or fusing these arthritic joints.”
The use of Autologous Biologic Therapy in a solution of concentrated growth factors has brought new hope to patients suffering from worn out arthritic joints. “The procedures we are developing are very similar to the stem cell therapy procedure Kobe Bryant, Tiger Woods and Alex Rodriguez received in Europe. Our clinical results are showing a rejuvenation of the knee’s overall function. MRI and standing x-rays confirm the space between the bones (cartilage area) is increasing. It’s early in the development stage, but if my use of regenerative cells continues to produce such positive outcomes, it’s quite possible we will have developed a new standard of care for millions suffering from arthritis,” says McKenna.
I also wanted to know if high-profile athletes, or those dreaming of being one (weekend warriors), were the only people who will benefit from this emerging point-of-care regenerative medicine?
McKenna answers, “I believe that almost any patient undergoing surgery can expect improved surgical results with this technology. This is evidenced by the fact that the most frequent application of regenerative cells is found in spine surgery. Surgeons utilize the phenomenal healing characteristics of regenerative cells to increase the formation of bone and aid in the formation of the fusion mass. The results of spinal fusions have been dramatically improved with the use of regenerative cells derived from bone marrow aspirate concentrate.”
McKenna goes on to explain, “Fractures that fail to heal are called non-union fractures and this is one of the most challenging issues in orthopedic surgery. The use of regenerative cells to heal these fracture non-unions continues to evolve. I have used mesenchymal stem cells with great success to aid in the healing of non-union fractures involving the clavicle, tibia and metatarsal bones of the foot.”
As a trained Trauma specialist, Dr. McKenna takes Emergency Room calls and sees many broken hips. Most of these fractures occur in elderly women who suffer from osteoporosis. “The introduction of bone marrow aspirate concentrate to augment the fixation of hip fractures has, in my clinical experience, increased the viability of the femoral head. I have seen 80-year-old patients walk into my office following hip fracture surgery with a femoral head that, on x-ray, looks unaffected by their previous fracture. Prior to the use of bone marrow aspirate concentrate this result would be uncommon,” states McKenna.
As we concluded the interview Dr. McKenna added with a great voice of confidence, “Certainly the future of orthopedics and all the surgical subspecialties will involve the use of regenerative biologics like stem cells. Unlocking the body’s ability to heal itself is the real future of patient care. I am proud to be involved as an innovator in this emerging technology.”
Dallas, TX (April 14, 2015) – Amniotic Therapies (www.amniotictherapies.com), a company specialized in the processing and distribution of human amniotic tissue products for the biologic and regenerative medicine segments of the healthcare market, announced that the introduction of new products at the 2015 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting has promoted growth for the business.
Amniotic Therapies’ new products included two additions to its AlphaGEMS flowable amniotic tissue line, AlphaGEMS Micro and AlphaGEMS Nano; and a new line of dehydrated amniotic tissue patches and discs for the ocular market, AlphaVISION.
The AAOS meeting is the largest annual orthopaedic meeting in the United States and was attended by over 31,000 orthopaedic surgeons and healthcare professionals.
Amniotic Therapies CEO, Neil Riordan, PhD said, “The AAOS meeting gave us the opportunity to showcase our products to physicians, health care professionals and current and potential distribution partners. Our products contain high levels of bioactive substances and growth factors that are important for healing and tissue regeneration. These factors also modulate inflammation and help reduce the formation of scar tissue. We are excited by the number of partnerships formed during and because of the meeting.”
Amniotic Therapies and its partner company, Biologic Therapies, conducted live presentations on amniotic tissue and regenerative medicine during the meeting. According to Scott Reynolds, VP of Marketing, “The presentations were well attended and were a great way to get members of our target market to witness the benefits of our products first hand.”